VAERS reports by lot

Pfizer COVID-19 lot EWO167: VAERS reports

32 VAERS reports list lot EWO167 as a Pfizer COVID-19 vaccine, received between 2021-05-01 and 2023-08-28. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
12%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4331%
Musculoskeletal2015%
Neurological1712%
Gastrointestinal1410%
Dermatological (non-injection-site)129%
Cardiac / Cardiovascular107%
Respiratory75%
Thrombotic / Hematological54%
Allergic / Anaphylactic43%
Psychiatric / Neuropsychiatric21%
Injection-site / Local reaction21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania4
Colorado3
New York3
Virginia2
Washington2
Florida2
Delaware1
New Mexico1
Illinois1
Minnesota1
Massachusetts1
Kansas1

Reports by month received

2021-058
2021-063
2021-074
2021-083
2021-095
2021-103
2021-122
2022-032
2022-061
2023-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.